Marrone Bio Innovations (NASDAQ:MBII) released its quarterly earnings results on Thursday. The basic materials company reported ($0.04) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.04), Morningstar.com reports. The firm had revenue of $8.72 million during the quarter, compared to analyst estimates of $6.18 million. Marrone Bio Innovations had a negative return on equity of 109.78% and a negative net margin of 82.82%.
MBII stock traded up $0.18 on Friday, hitting $1.72. 284,825 shares of the company’s stock were exchanged, compared to its average volume of 85,644. Marrone Bio Innovations has a 12-month low of $1.10 and a 12-month high of $2.18. The company has a debt-to-equity ratio of 1.48, a current ratio of 2.66 and a quick ratio of 1.94. The company has a market cap of $170.50 million, a price-to-earnings ratio of -8.19 and a beta of -0.12.
In related news, major shareholder Van Herk Investments B.V. sold 1,500,000 shares of the business’s stock in a transaction on Thursday, February 21st. The stock was sold at an average price of $1.57, for a total transaction of $2,355,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.90% of the stock is owned by insiders.
Separately, National Securities started coverage on Marrone Bio Innovations in a research report on Wednesday, January 23rd. They issued a “buy” rating and a $2.50 price target for the company.
ILLEGAL ACTIVITY NOTICE: “Marrone Bio Innovations (MBII) Posts Quarterly Earnings Results, Hits Estimates” was posted by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://dakotafinancialnews.com/2019/05/11/marrone-bio-innovations-mbii-posts-quarterly-earnings-results-hits-estimates.html.
About Marrone Bio Innovations
Marrone Bio Innovations, Inc provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation.
Recommended Story: What is the cash asset ratio?
Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.